Changes to Etac's Board of Directors

In October, Jon Giacomin will join the Board as a new director. Jon brings more than 30 years of experience from the US healthcare industry, including nearly 20 years at Cardinal Health, where he ultimately led the company's Medical and Pharmaceutical segments. His extensive leadership experience and industry expertise will support Etac's continued growth and development.

At the same time, Paul Leeflang will step down from the Board. The Board, Etac's owner Nordstjernan, and the Etac management team would like to express their sincere appreciation for Paul's valuable contributions and commitment during his tenure.

We thank Paul for his service and welcome Jon to the Board.